ATE342276T1 - Nährstoffe aus sojabohnenprotein - Google Patents

Nährstoffe aus sojabohnenprotein

Info

Publication number
ATE342276T1
ATE342276T1 AT00930241T AT00930241T ATE342276T1 AT E342276 T1 ATE342276 T1 AT E342276T1 AT 00930241 T AT00930241 T AT 00930241T AT 00930241 T AT00930241 T AT 00930241T AT E342276 T1 ATE342276 T1 AT E342276T1
Authority
AT
Austria
Prior art keywords
lunasin
polypeptide
provides methods
unit dosage
active unit
Prior art date
Application number
AT00930241T
Other languages
English (en)
Inventor
Lumen Benito O De
Alfredo F Galves
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE342276T1 publication Critical patent/ATE342276T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Tea And Coffee (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00930241T 1999-04-30 2000-04-30 Nährstoffe aus sojabohnenprotein ATE342276T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/303,814 US6391848B1 (en) 1999-04-30 1999-04-30 Soybean protein nutraceuticals

Publications (1)

Publication Number Publication Date
ATE342276T1 true ATE342276T1 (de) 2006-11-15

Family

ID=23173833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00930241T ATE342276T1 (de) 1999-04-30 2000-04-30 Nährstoffe aus sojabohnenprotein

Country Status (11)

Country Link
US (1) US6391848B1 (de)
EP (1) EP1173476B1 (de)
JP (1) JP3850667B2 (de)
AT (1) ATE342276T1 (de)
AU (1) AU762977B2 (de)
CA (1) CA2365266C (de)
DE (1) DE60031259T2 (de)
DK (1) DK1173476T3 (de)
ES (1) ES2273693T3 (de)
PT (1) PT1173476E (de)
WO (1) WO2000066625A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001250963A1 (en) * 2000-03-24 2001-10-08 Filgen Biosciences, Inc. Peptides binding to non-acetylated H3 and H4 histones for cancer therapy
US7279564B2 (en) * 2003-11-06 2007-10-09 Genencor International, Inc. Expression in filamentous fungi of protease inhibitors and variants thereof
US7829277B2 (en) * 2004-03-01 2010-11-09 The Regents Of The University Of California Methods for identifying compounds that suppress chemically-induced carcinogenesis
US20070054031A1 (en) * 2005-09-02 2007-03-08 Keshun Liu Methods of extracting, concentrating and fractionating proteins and other chemical components
US20090113889A1 (en) * 2006-02-28 2009-05-07 Subir Roychoudhury Catalytic burner for stirling engine
US8598111B2 (en) * 2006-09-15 2013-12-03 Soy Labs, Llc Products and methods using soy peptides to lower total and LDL cholesterol levels
PL2061313T3 (pl) 2006-09-16 2014-01-31 Soy Labs Llc Zastosowanie peptydu sojowego (lunazyny) do obniżania poziomu cholesterolu całkowitego i ldl
US7731995B2 (en) * 2006-09-16 2010-06-08 Alfredo Flores Galvez Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
US8759613B1 (en) 2009-10-26 2014-06-24 University Of Louisville Research Foundation, Inc. Method of producing a lunasin polypeptide in plants
US9066906B2 (en) * 2009-11-11 2015-06-30 University Of Louisville Research Foundation, Inc. Lunasin-containing complex and purification of lunasin from plants
US20160015776A1 (en) 2013-03-15 2016-01-21 Soy Labs, Llc Products and methods using lunasin enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
CN108034670B (zh) * 2017-12-25 2021-03-30 大连大学 一种食源性大豆生物活性肽Lunasin的无柱式、低成本制备方法
PL447389A1 (pl) * 2023-12-29 2025-06-30 Pharmacy Research Institute Spółka Z Ograniczoną Odpowiedzialnością Sposób pozyskiwania preparatu o podwyższonej zawartości lunazyny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217717A (en) * 1990-09-06 1993-06-08 Central Soya Company, Inc. Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy
US5614198A (en) * 1995-07-25 1997-03-25 The Trustees Of The University Of Pennsylvania Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
US5850016A (en) * 1996-03-20 1998-12-15 Pioneer Hi-Bred International, Inc. Alteration of amino acid compositions in seeds
US6107287A (en) * 1997-09-25 2000-08-22 The Regents Of The University Of California Lunasin peptides

Also Published As

Publication number Publication date
WO2000066625A1 (en) 2000-11-09
EP1173476A4 (de) 2002-08-28
EP1173476A1 (de) 2002-01-23
CA2365266A1 (en) 2001-10-09
DK1173476T3 (da) 2007-02-19
US6391848B1 (en) 2002-05-21
DE60031259D1 (de) 2006-11-23
ES2273693T3 (es) 2007-05-16
CA2365266C (en) 2010-10-12
EP1173476B1 (de) 2006-10-11
JP2002543219A (ja) 2002-12-17
AU4809600A (en) 2000-11-17
DE60031259T2 (de) 2007-04-12
JP3850667B2 (ja) 2006-11-29
AU762977B2 (en) 2003-07-10
PT1173476E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
EP3001990A1 (de) Mischung zur transdermalen abgabe von verbindungen mit niedrigem und hohem molekulargewicht
DE60031259D1 (de) Nährstoffe aus sojabohnenprotein
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
GEP20053473B (en) High Potency Dihydroergotamine Compositions
NZ581589A (en) Solubilized sterile injectable formulation of docetaxel without Tween 80
ATE75945T1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
KR20190101990A (ko) 펩티드 wkdeagkplvk를 포함하는 조성물
CN106389330A (zh) 用于递送治疗剂的方法和组合物
AR017973A1 (es) Formulacion farmaceutica isotonica, uso de dicha formulacion en la preparacion de un medicamento para uso en la terapia de una enfermedad autoinmune,y metodo para mejorar el almacenamiento de un anticuerpo
Maggio et al. Oral delivery of octreotide acetate in Intravail® improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss Webster mice
ES2327640T3 (es) Sustancias biologicamente activas a partir de un peptido intestinal vasoactivo para el tratamiento de afecciones pulmonares intersticiales.
EP1765310B1 (de) Mischung zur transdermalen abgabe von verbindungen mit niedrigem und hohem molekulargewicht
DE60133654D1 (de) Arzneimittel enthaltend analgetische peptide
IL161670A0 (en) Thymosin alpha 1 peptide/polymer conjugates
DE69926881D1 (de) Zubereitungen zur aknebehandlung
JP2002530353A5 (de)
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
NO20042100L (no) Fremgangsmate for administrering av et tymosinalfa 1-peptid
JP4950571B2 (ja) コラーゲン産生促進能を有する組成物
DE60036199D1 (de) Proteaseresistente flint-analoge
CN120166995B (zh) 具有促进毛发生长和抑制毛发脱落活性的肽及其用途
BR9917605A (pt) Composição substituta de plasma
GB2616223A9 (en) Oral formulation of biologically active material conjugate having biotin moiety, fatty acid moiety, or combination thereof coupled thereto
CN107337714B (zh) 抗组织胺、抗敏的肽及其应用
TW202302628A (zh) 乳鐵蛋白的衍生胜肽及其促進及/或增加油脂生成的用途

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173476

Country of ref document: EP